Are there sex differences in placebo analgesia during visceral pain processing? A fMRI study in healthy subjects

Neurogastroenterology and Motility

Volumn 26, Issue 12, 2014, Pages 1743-1753

  Theysohn, N ^a   Schmid, J ^a   Icenhour, A ^a   Mewes, C ^a   Forsting, M ^a   Gizewski, E R ^b   Schedlowski, M ^a   Elsenbruch, S ^a   Benson, S ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Expectation; fMRI; Placebo analgesia; Sex differences; Visceral pain

Indexed keywords

ANALGESIC AGENT; PLACEBO;

ADULT; ANALGESIA; BRAIN; CONTROLLED STUDY; DRUG EFFECTS; FEMALE; HUMAN; MALE; NOCICEPTION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSIOLOGY; PLACEBO EFFECT; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SEXUAL DEVELOPMENT; VISCERAL PAIN;

ADULT; ANALGESIA; ANALGESICS; BRAIN; FEMALE; HEALTHY VOLUNTEERS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PAIN MEASUREMENT; PAIN PERCEPTION; PAIN THRESHOLD; PLACEBO EFFECT; PLACEBOS; SEX CHARACTERISTICS; VISCERAL PAIN;

EID: 84911483238     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12454     Document Type: Article

References (37)

1. Berkley KJ. Sex differences in pain. Behav Brain Sci 1997; 20: 371-80; discussion 435-513.
2. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL 3rd. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 2009; 10: 447-85.
3. Unruh AM. Gender variations in clinical pain experience. Pain 1996; 65: 123-67.
4. Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, Sperber AD. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006; 130: 1435-46.
5. Elsenbruch S. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun 2011; 25: 386-94.
6. Enck P, Bingel U, Schedlowski M, Rief W. The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov 2013; 12: 191-204.
7. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson EE, Kirsch I, Schyner RN et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003.
8. Franconi F, Campesi I, Occhioni S, Antonini P, Murphy MF. Sex and gender in adverse drug events, addiction, and placebo. Handb Exp Pharmacol 2012; 214: 107-26.
9. Aslaksen PM, Bystad M, Vambheim SM, Flaten MA. Gender differences in placebo analgesia: event-related potentials and emotional modulation. Psychosom Med 2011; 73: 193-9.
10. Flaten MA, Aslaksen PM, Finset A, Simonsen T, Johansen O. Cognitive and emotional factors in placebo analgesia. J Psychosom Res 2006; 61: 81-9.
11. Butcher BE, Carmody JJ. Sex differences in analgesic response to ibuprofen are influenced by expectancy: a randomized, crossover, balanced placebo-designed study. Eur J Pain 2012; 16: 1005-13.
12. Klosterhalfen S, Kellermann S, Braun S, Kowalski A, Schrauth M, Zipfel S, Enck P. Gender and the nocebo response following conditioning and expectancy. J Psychosom Res 2009; 66: 323-8.
13. Weimer K, Schulte J, Maichle A, Muth ER, Scisco JL, Horing B, Enck P, Klosterhalfen S. Effects of ginger and expectations on symptoms of nausea in a balanced placebo design. PLoS ONE 2012; 7: e49031.
14. Kelley JM, Lembo AJ, Ablon JS, Villanueva JJ, Conboy LA, Levy R, Marci CD, Kerr CE et al. Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med 2009; 71: 789-97.
15. Cervero F. Visceral versus somatic pain: similarities and differences. Dig Dis 2009; 27(Suppl. 1): 3-10.
16. Schmid J, Theysohn N, Gass F, Benson S, Gramsch C, Forsting M, Gizewski ER, Elsenbruch S. Neural mechanisms mediating positive and negative treatment expectations in visceral pain: a functional magnetic resonance imaging study on placebo and nocebo effects in healthy volunteers. Pain 2013; 154: 2372-80.
17. Elsenbruch S, Kotsis V, Benson S, Rosenberger C, Reidick D, Schedlowski M, Bingel U, Theysohn N et al. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain 2012; 153: 382-90.
18. Compton P, Charuvastra VC, Ling W. Effect of oral ketorolac and gender on human cold pressor pain tolerance. Clin Exp Pharmacol P 2003; 30: 759-63.
19. Averbuch M, Katzper M. Gender and the placebo analgesic effect in acute pain. Clin Pharmacol Ther 2001; 70: 287-91.
20. Herrmann-Lingen CBU, Snaith RP. Hospital Anxiety and Depression Scale (HADS) - Deutsche Version, 2nd edn. Bern: Hans Huber, 2005.
21. Benson S, Kattoor J, Wegner A, Hammes F, Reidick D, Grigoleit JS, Engler H, Oberbeck R et al. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain 2012; 153: 794-9.
22. Benson S, Kotsis V, Rosenberger C, Bingel U, Forsting M, Schedlowski M, Gizewski ER, Elsenbruch S. Behavioural and neural correlates of visceral pain sensitivity in healthy men and women: does sex matter? Eur J Pain 2012; 16: 349-58.
23. Elsenbruch S, Schmid J, Basler M, Cesko E, Schedlowski M, Benson S. How positive and negative expectations shape the experience of visceral pain: an experimental pilot study in healthy women. Neurogastroenterol Motil 2012; 24: 914-e460.
24. Kotsis V, Benson S, Bingel U, Forsting M, Schedlowski M, Gizewski ER, Elsenbruch S. Perceived treatment group affects behavioral and neural responses to visceral pain in a deceptive placebo study. Neurogastroenterol Motil 2012; 24: 935-e462.
25. Lee HF, Hsieh JC, Lu CL, Yeh TC, Tu CH, Cheng CM, Niddam DM, Lin HC et al. Enhanced affect/cognition-related brain responses during visceral placebo analgesia in irritable bowel syndrome patients. Pain 2012; 153: 1301-10.
26. Price DD, Craggs J, Verne GN, Perlstein WM, Robinson ME. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 2007; 127: 63-72.
27. Amanzio M, Benedetti F, Porro CA, Palermo S, Cauda F. Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain. Hum Brain Mapp 2013; 34: 738-52.
28. Bingel U, Wanigasekera V, Wiech K, Ni Mhuircheartaigh R, Lee MC, Ploner M, Tracey I. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011; 3: 70ra14.
29. Craig AD. How do you feel-now? The anterior insula and human awareness. Nat Rev Neurosci 2009; 10: 59-70.
30. Wiech K, Lin CS, Brodersen KH, Bingel U, Ploner M, Tracey I. Anterior insula integrates information about salience into perceptual decisions about pain. J Neurosci 2010; 30: 16324-31.
31. Linnman C, Rougemont-Bucking A, Beucke JC, Zeffiro TA, Milad MR. Unconditioned responses and functional fear networks in human classical conditioning. Behav Brain Res 2011; 221: 237-45.
32. Lu HC, Hsieh JC, Lu CL, Niddam DM, Wu YT, Yeh TC, Cheng CM, Chang FY et al. Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: a 3T-fMRI study. Pain 2010; 148: 75-83.
33. Vase L, Robinson ME, Verne GN, Price DD. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 2005; 115: 338-47.
34. Vase L, Robinson ME, Verne GN, Price DD. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 2003; 105: 17-25.
35. Verne GN, Robinson ME, Vase L, Price DD. Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients. Pain 2003; 105: 223-30.
36. Aslaksen PM, Myrbakk IN, Hoifodt RS, Flaten MA. The effect of experimenter gender on autonomic and subjective responses to pain stimuli. Pain 2007; 129: 260-8.
37. Gijsbers K, Nicholson F. Experimental pain thresholds influenced by sex of experimenter. Percept Mot Skills 2005; 101: 803-7.